Found: 153
Select item for more details and to access through your institution.
Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 10, p. 1066, doi. 10.1001/jamadermatol.2024.2701
- By:
- Publication type:
- Article
Vaccination Guidelines for Patients with Immune-Mediated Disorders on Immunosuppressive Therapies—Executive Summary.
- Published in:
- Journal of the Canadian Association of Gastroenterology, 2019, v. 2, n. 4, p. 149, doi. 10.1093/jcag/gwy069
- By:
- Publication type:
- Article
Triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel for moderate-to-severe acne in children and adolescents: Randomized phase 2 study.
- Published in:
- Pediatric Dermatology, 2023, v. 40, n. 3, p. 452, doi. 10.1111/pde.15283
- By:
- Publication type:
- Article
Safety of Janus kinase (JAK) inhibitors in the short‐term treatment of atopic dermatitis.
- Published in:
- International Journal of Dermatology, 2022, v. 61, n. 6, p. 746, doi. 10.1111/ijd.15853
- By:
- Publication type:
- Article
Could it be gluten? Additional skin conditions associated with celiac disease.
- Published in:
- International Journal of Dermatology, 2022, v. 61, n. 1, p. 33, doi. 10.1111/ijd.15750
- By:
- Publication type:
- Article
A Canadian online survey to evaluate awareness and treatment satisfaction in individuals with moderate to severe plaque psoriasis.
- Published in:
- International Journal of Dermatology, 2010, v. 49, n. 12, p. 1368, doi. 10.1111/j.1365-4632.2010.04660.x
- By:
- Publication type:
- Article
Safety profile of intravenous and subcutaneous siplizumab, an anti-CD2 monoclonal antibody, for the treatment of plaque psoriasis: results of two randomized, double-blind, placebo-controlled studies.
- Published in:
- International Journal of Dermatology, 2010, v. 49, n. 7, p. 818, doi. 10.1111/j.1365-4632.2010.04512.x
- By:
- Publication type:
- Article
Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: A phase IIIb, randomized, controlled trial.
- Published in:
- 2006
- By:
- Publication type:
- Other
Effect of pimecrolimus cream 1% on the long-term course of pediatric atopic dermatitis.
- Published in:
- International Journal of Dermatology, 2004, v. 43, n. 12, p. 978, doi. 10.1111/j.1365-4632.2004.02121.x
- By:
- Publication type:
- Article
Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive Summary.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Meaningful Change Thresholds for the Psoriasis Symptoms and Signs Diary: A Secondary Analysis of a Randomized Clinical Trial.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 2, p. 204, doi. 10.1001/jamadermatol.2023.5058
- By:
- Publication type:
- Article
Follow-up of Patients With Keratinocyte Carcinoma: A Systematic Review of Clinical Practice Guidelines.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis: The IXORA-PEDS Randomized Clinical Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis: Analysis of Follow-up Data From the Measure Up 1 and Measure Up 2 Randomized Clinical Trials.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: A Phase 3 Randomized Clinical Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Emerging paradigm shift toward proactive topical treatment of psoriasis: A narrative review.
- Published in:
- Dermatologic Therapy, 2021, v. 34, n. 6, p. 1, doi. 10.1111/dth.15104
- By:
- Publication type:
- Article
Long-term efficacy of up to 15 months’ efalizumab therapy in patients with moderate-to-severe chronic plaque psoriasis.
- Published in:
- Dermatologic Therapy, 2008, v. 21, p. S6, doi. 10.1111/j.1529-8019.2008.00235.x
- By:
- Publication type:
- Article
Signal Detection and Methodological Limitations in a Real-World Registry: Learnings from the Evaluation of Long-Term Safety Analyses in PSOLAR.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Safety of Efalizumab Therapy in Patients with Moderate to Severe Psoriasis: An Open-Label Extension of a Phase IIIb Trial.
- Published in:
- Drug Safety, 2008, v. 31, n. 8, p. 715, doi. 10.2165/00002018-200831080-00008
- By:
- Publication type:
- Article
Efficacy and Safety of Candidate Biosimilar CT-P43 Versus Originator Ustekinumab in Moderate to Severe Plaque Psoriasis: 28-Week Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study.
- Published in:
- BioDrugs, 2024, v. 38, n. 1, p. 121, doi. 10.1007/s40259-023-00630-5
- By:
- Publication type:
- Article
Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on Apremilast.
- Published in:
- BioDrugs, 2015, v. 29, n. 5, p. 327, doi. 10.1007/s40259-015-0144-3
- By:
- Publication type:
- Article
Time to Loss of Response following Withdrawal of Ixekizumab in Patients with Moderate-to-Severe Psoriasis.
- Published in:
- Acta Dermato-Venereologica, 2022, v. 102, p. 1, doi. 10.2340/actadv.v102.1984
- By:
- Publication type:
- Article
Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials.
- Published in:
- JAMA: Journal of the American Medical Association, 2022, v. 328, n. 11, p. 1073, doi. 10.1001/jama.2022.15632
- By:
- Publication type:
- Article
Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled study.
- Published in:
- Health & Quality of Life Outcomes, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1477-7525-11-82
- By:
- Publication type:
- Article
Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled study.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Effectiveness and safety of secukinumab updosing in patients with moderate to severe plaque psoriasis: data from the PURE registry.
- Published in:
- Archives of Dermatological Research, 2024, v. 316, n. 7, p. 1, doi. 10.1007/s00403-024-03122-w
- By:
- Publication type:
- Article
Humanized anti-CD2 monoclonal antibody treatment of plaque psoriasis: efficacy and pharmacodynamic results of two randomized, double-blind, placebo-controlled studies of intravenous and subcutaneous siplizumab.
- Published in:
- Archives of Dermatological Research, 2009, v. 301, n. 6, p. 429, doi. 10.1007/s00403-009-0961-7
- By:
- Publication type:
- Article
Deucravacitinib in moderate‐to‐severe plaque psoriasis: Pooled safety and tolerability over 52 weeks from two phase 3 trials (POETYK PSO‐1 and PSO‐2).
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 8, p. 1543, doi. 10.1111/jdv.19925
- By:
- Publication type:
- Article
Upadacitinib treatment withdrawal and retreatment in patients with moderate‐to‐severe atopic dermatitis: Results from a phase 2b, randomized, controlled trial.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 12, p. 2558, doi. 10.1111/jdv.19391
- By:
- Publication type:
- Article
Abrocitinib efficacy and safety in patients with moderate‐to‐severe atopic dermatitis: Results from phase 3 studies, including the long‐term extension JADE EXTEND study.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 10, p. 2056, doi. 10.1111/jdv.19280
- By:
- Publication type:
- Article
Guselkumab for the treatment of patients with moderate‐to‐severe hidradenitis suppurativa: A phase 2 randomized study.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 10, p. 2098, doi. 10.1111/jdv.19252
- By:
- Publication type:
- Article
Rapid pruritus reduction with ruxolitinib cream treatment in patients with atopic dermatitis.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 1, p. 137, doi. 10.1111/jdv.18571
- By:
- Publication type:
- Article
Real‐world, long‐term treatment patterns of commonly used biologics in Canadian patients with moderate‐to‐severe chronic plaque psoriasis.
- Published in:
- Journal of Dermatology, 2022, v. 49, n. 1, p. 95, doi. 10.1111/1346-8138.16214
- By:
- Publication type:
- Article
Tofacitinib for the treatment of moderate to severe chronic plaque psoriasis in Japanese patients: Subgroup analyses from a randomized, placebo-controlled phase 3 trial.
- Published in:
- Journal of Dermatology, 2017, v. 44, n. 11, p. 1228, doi. 10.1111/1346-8138.13956
- By:
- Publication type:
- Article
Managing cardiovascular risk in patients with chronic inflammatory diseases.
- Published in:
- Clinical Rheumatology, 2012, v. 31, n. 4, p. 585, doi. 10.1007/s10067-011-1921-0
- By:
- Publication type:
- Article
Predictors of Topical Use in Psoriasis Patients in the REFINE Study.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2016, v. 20, n. 2, p. 106, doi. 10.1177/1203475415604322
- By:
- Publication type:
- Article
A Novel Aerosol Foam Formulation of Calcipotriol and Betamethasone Has No Impact on HPA Axis and Calcium Homeostasis in Patients With Extensive Psoriasis Vulgaris.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2016, v. 20, n. 1, p. 44, doi. 10.1177/1203475415597094
- By:
- Publication type:
- Article
Long-term Management of Moderate to Severe Plaque Psoriasis Patients With Etanercept: A Case Series.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2015, v. 19, n. 6, p. 561, doi. 10.1177/1203475415584511
- By:
- Publication type:
- Article
Preparing for Subsequent Entry Biologics in Dermatology and Rheumatology in Canada.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2013, v. 17, n. 5, p. 340, doi. 10.2310/7750.2013.13006
- By:
- Publication type:
- Article
Understanding and Assessing Potential Serious Adverse Events: A Practical Approach to Understanding the Benefits and Harm of Psoriasis Treatments.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2013, v. 17, n. 3, p. 189, doi. 10.2310/7750.2012.12046
- By:
- Publication type:
- Article
Examining the Risk of Cardiovascular Disease in Patients with Psoriasis: A Critical Review.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2013, v. 17, n. 2, p. 89, doi. 10.2310/7750.2012.11126
- By:
- Publication type:
- Article
Biologic Therapy in Psoriasis: Perspectives on Associated Risks and Patient Management.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2012, v. 16, n. 3, p. 153, doi. 10.1177/120347541201600305
- By:
- Publication type:
- Article
Topical Psoriasis Therapy in the Age of Biologics: Evidence-Based Treatment Recommendations.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2011, v. 15, n. 6, p. 309, doi. 10.2310/7750.2011.10080
- By:
- Publication type:
- Article
Canadian Guidelines for the Management of Plaque Psoriasis: Overview.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2011, v. 15, n. 4, p. 210, doi. 10.2310/7750.2011.10066
- By:
- Publication type:
- Article
Epidemiology of Moderate-to-Severe Plaque Psoriasis in a Canadian Surveyed Population.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2010, v. 14, n. 4, p. 167, doi. 10.2310/7750.2010.09066
- By:
- Publication type:
- Article
Psoriasis Care: New and Emerging Pharmacologic Trends.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2010, v. 14, n. 3, p. 119, doi. 10.2310/7750.2010.09039
- By:
- Publication type:
- Article
Patterns of Combination Therapy with Alefacept for the Treatment of Psoriasis in Canada in the AWARE Study.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2009, v. 13, n. S3, p. S131, doi. 10.2310/7750.2009.00031
- By:
- Publication type:
- Article
Update on Alefacept Safety.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2009, v. 13, n. S3, p. S139, doi. 10.2310/7750.2009.00032
- By:
- Publication type:
- Article
The AWARE Study: Methodology and Baseline Characteristics.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2009, v. 13, n. S3, p. S113, doi. 10.2310/7750.2009.00029
- By:
- Publication type:
- Article